SCHEMBL821913

SCHEMBL821913

C[Si](C)(Cc1ccccc1)N([Nd](Cl)N([Si](C)(C)Cc1ccccc1)[Si](C)(C)Cc1ccccc1)[Si](C)(C)Cc1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
TBXAS1 P24557 1/20 0.36
QPCT Q16769 1/20 0.36
CYP4Z1 Q86W10 1/20 0.36
QPCTL Q9NXS2 1/20 0.36
ALDH1A1 P00352 3/20 0.35
TSHR P16473 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.34
TDP1 Q9NUW8 2/20 0.34
KDM4E B2RXH2 1/20 0.34
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL821652 0.80 NR1H2 (0.37) CYP19A1CYP1A2CYP2D6ALDH1A1TSHR
SCHEMBL821353 0.80 PIM1 (0.36) CYP19A1CYP1A2CYP3A4CYP2D6POLB
SCHEMBL822285 0.80 ALDH1A1 (0.35) CYP19A1CYP1A2CYP2D6ALDH1A1TSHR
SCHEMBL8777923 0.74 TSHR (0.46) CYP3A4ALDH1A1TSHRLMNATP53
Hydrochloric Acid SCHEMBL821912 0.73 ALDH1A1 (0.37) CYP19A1CYP1A2CYP2D6ALDH1A1TSHR
SCHEMBL28093108 0.73 TP53 (0.43) CYP19A1CYP3A4MAPTALDH1A1TSHR
SCHEMBL5514135 0.70 TSHR (0.46) ALDH1A1TSHRTP53TDP1NR1H2
Iodide SCHEMBL822284 0.69 TSHR (0.37) CYP3A4MAPTALDH1A1TSHRLMNA
Bromide SCHEMBL821352 0.69 ALDH1A1 (0.37) CYP3A4MAPTALDH1A1TSHRLMNA
Hydrochloric Acid SCHEMBL821914 0.69 ALDH1A1 (0.37) CYP3A4MAPTALDH1A1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153545-B2 Process for homo—or copolymerization of conjugated olefins STYRON EUROPE GMBH (CH) 2012-04-10 US disclosed
US-20110160041-A1 PROCESS FOR HOMO - OR COPOLYMERIZATION OF CONJUGATED OLEFINS STYRON EUROPE GMBH 2011-06-30 US disclosed
US-7915194-B2 Process for homo- or copolymerization of conjugated olefins STYRON EUROPE GMBH (CH) 2011-03-29 US disclosed
EP-2267046-A1 Process for homo- or copolymerization of conjugated olefines DOW GLOBAL TECHNOLOGIES INC. (US) 2010-12-29 EP disclosed
US-20100248947-A1 PROCESS FOR HOMO - OR COPOLYMERIZATION OF CONJUGATED OLEFINS DOW GLOBAL TECHNOLOGIES INC. (US) 2010-09-30 US disclosed
US-7612009-B2 Process for homo-or copolymerization of conjugated olefines DOW GLOBAL TECHNOLOGIES, INC. (US) 2009-11-03 US disclosed
US-20060142145-A1 Process for homo-or copolymerization of conjugated olefines TRINSEO EUROPE GMBH (CH) 2006-06-29 US disclosed
EP-1597292-A2 PROCESS FOR HOMO- OR COPOLYMERIZATION OF CONJUGATED OLEFINES DOW GLOBAL TECHNOLOGIES INC. (US) 2005-11-23 EP disclosed
WO-2004076504-A2 PROCESS FOR HOMO- OR COPOLYMERIZATION OF CONJUGATED OLEFINES DOW GLOBAL TECHNOLOGIES, INC. (US) 2004-09-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160041-A1 PROCESS FOR HOMO - OR COPOLYMERIZATION OF CONJUGATED OLEFINS F12, ETFB, F2 CYP19A1 2222/4885CYP1A2 2759/4885CYP3A4 2775/4885
US-20060142145-A1 Process for homo-or copolymerization of conjugated olefines ETFB, F12, F2 CYP19A1 2537/4885CYP1A2 2762/4885CYP3A4 2483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.